Anti-D Rh0 immunoglobulin (Biotest)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-D Rh0 immunoglobulin (Biotest)
Drug Alias NameAnti-D polyclonal antibody抗 Rh-D 球蛋白Anti-D immune globulin - BiotestRh0 (D) Immune Globulin Intravenous (Human)Nabi Anti-D
ClassificationBiologics > Blood components
Mechanisms of ActionPlatelet activating factor receptor stimulants
TargetsPlatelet activating factor receptor
Therapy Area/IndicationsPurpura, Thrombocytopenic, Idiopathic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiotest Pharma GmbhNabi Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotest AgNabi Biopharmaceuticals
Active IndicationsN/A
Inactive IndicationsPurpura, Thrombocytopenic, Idiopathic

Other Information

ATC CodeN/A
Related LinksN/A